AAC
Home Help [Feedback] [For Subscribers] [Archive] [Search] --
AAC Accepts, published online ahead of print on 23 April 2007
This Article
Right arrow Full Text (PDF)
Right arrow Other Versions of this Article:
AAC.01606-06v1
51/7/2412    most recent
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Copyright Information
Right arrow Books from ASM Press
Right arrow MicrobeWorld
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Azpiroz, M. F.
Right arrow Articles by Laviña, M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Azpiroz, M. F.
Right arrow Articles by Laviña, M.
Antimicrob. Agents Chemother. doi:10.1128/AAC.01606-06
Copyright (c) 2007, American Society for Microbiology and/or the Listed Authors/Institutions. All Rights Reserved.

MODULAR STRUCTURE OF MICROCIN H47 AND COLICIN V

María F. Azpiroz and Magela Laviña*

Sección Fisiología y Genética Bacterianas, Facultad de Ciencias, Iguá 4225, Montevideo 11.400, Uruguay

* To whom correspondence should be addressed. Email: magela{at}fcien.edu.uy.


   Abstract

Microcins are gene-encoded peptide antibiotics produced by enterobacteria which act on strains of Gram negative bacteria. In this work, we concentrated on higher-molecular-mass microcins, i.e. those possessing 60 or more amino acids. They can be subdivided into unmodified and post-translationally modified peptides. In both cases, they exhibit conserved C-terminal sequences which appear to be characteristic of each subgroup. In the hypothesis that these sequences could correspond to domains, gene fusions between the activity genes for the unmodified microcin colicin V and the modified microcin H47 were constructed. These two microcins differ in their mode of synthesis, in their uptake, in their target and in their specific immunity. Through this experimental approach, chimeric peptides with exchanged C-terminal sequences were encoded. Cells carrying the fusions in different genetic contexts were then assayed for antibiotic production. Many of them produced antibiotic activities with recombinant properties: the toxicity of one microcin and the mode of uptake of the other. The results led to the identification of a modular structure of colicin V and of microcin H47, with the recognition of two domains in their peptide chains: a toxic N-terminal domain and an uptake C-terminal domain. This modular design would be shared by other microcins from each subgroup.







Home Help [Feedback] [For Subscribers] [Archive] [Search] --
Clin. Vaccine Immunol. Clin. Microbiol. Rev.
J. Clin. Microbiol. ALL ASM JOURNALS

Copyright © 2007 by the American Society for Microbiology. All rights reserved.